Kenneth S Kendler1, Charles O Gardner, Amy Fiske, Margaret Gatz. 1. Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, Virginia 23298-0126, USA. kendler@vcu.edu
Abstract
CONTEXT: Major depresssion (MD) and coronary artery disease (CAD) frequently co-occur. The mechanisms of comorbidity are uncertain. OBJECTIVE: To clarify sources of MD-CAD comorbidity. DESIGN: Major depression was assessed at the time of the personal interview, and CAD from hospital discharge records and death certificates. SETTING: Swedish population-based twin registry. PARTICIPANTS: The study included 30 374 twins with a mean age of 57 years. Main Outcome Measure Modified DSM-IV diagnosis of MD or diagnosis of CAD. RESULTS: Lifetime association between MD and CAD was modest (odds ratio, approximately 1.3). In time-dependent Cox analyses, onset of CAD produced concurrent and ongoing hazard ratios for MD of 2.83 and 1.75. These risks increased if the diagnosis of CAD was restricted to myocardial infarction. Onset of MD increased the concurrent and ongoing hazard ratios for CAD to 2.53 and 1.17. The ongoing CAD risk was strongly associated with depressive severity and recurrence. Twin models showed that the modest comorbidity between MD and CAD in women arose primarily from shared genetic effects, although the genetic correlation was small (+0.16). In men, the source of comorbidity was moderated by age, being environmental in older members and largely genetic in younger members of the sample. CONCLUSIONS: Although the MD-CAD relationship across the lifespan is modest, time-dependent models reveal stronger associations. The sustained effect of CAD onset on MD risk is much stronger than vice versa. The effect of MD on CAD is largely acute, and the longer-term effects are apparently mediated via depressive recurrence. When examined separately, in men, environmental effects, which are often acute, play a large role in MD-CAD comorbidity, whereas in women, chronic effects, which are in part genetic, are more important. In men, genetic sources of MD-CAD comorbidity are more important in younger members of the sample.
CONTEXT: Major depresssion (MD) and coronary artery disease (CAD) frequently co-occur. The mechanisms of comorbidity are uncertain. OBJECTIVE: To clarify sources of MD-CAD comorbidity. DESIGN: Major depression was assessed at the time of the personal interview, and CAD from hospital discharge records and death certificates. SETTING: Swedish population-based twin registry. PARTICIPANTS: The study included 30 374 twins with a mean age of 57 years. Main Outcome Measure Modified DSM-IV diagnosis of MD or diagnosis of CAD. RESULTS: Lifetime association between MD and CAD was modest (odds ratio, approximately 1.3). In time-dependent Cox analyses, onset of CAD produced concurrent and ongoing hazard ratios for MD of 2.83 and 1.75. These risks increased if the diagnosis of CAD was restricted to myocardial infarction. Onset of MD increased the concurrent and ongoing hazard ratios for CAD to 2.53 and 1.17. The ongoing CAD risk was strongly associated with depressive severity and recurrence. Twin models showed that the modest comorbidity between MD and CAD in women arose primarily from shared genetic effects, although the genetic correlation was small (+0.16). In men, the source of comorbidity was moderated by age, being environmental in older members and largely genetic in younger members of the sample. CONCLUSIONS: Although the MD-CAD relationship across the lifespan is modest, time-dependent models reveal stronger associations. The sustained effect of CAD onset on MD risk is much stronger than vice versa. The effect of MD on CAD is largely acute, and the longer-term effects are apparently mediated via depressive recurrence. When examined separately, in men, environmental effects, which are often acute, play a large role in MD-CAD comorbidity, whereas in women, chronic effects, which are in part genetic, are more important. In men, genetic sources of MD-CAD comorbidity are more important in younger members of the sample.
Authors: Jeffrey F Scherrer; Hong Xian; Kathleen K Bucholz; Seth A Eisen; Michael J Lyons; Jack Goldberg; Ming Tsuang; William R True Journal: Psychosom Med Date: 2003 Jul-Aug Impact factor: 4.312
Authors: Heather S Lett; James A Blumenthal; Michael A Babyak; Andrew Sherwood; Timothy Strauman; Clive Robins; Mark F Newman Journal: Psychosom Med Date: 2004 May-Jun Impact factor: 4.312
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Paul G Surtees; Nicholas W J Wainwright; Robert N Luben; Nicholas J Wareham; Sheila A Bingham; Kay-Tee Khaw Journal: Am J Psychiatry Date: 2008-02-01 Impact factor: 18.112
Authors: Viola Vaccarino; Jack Goldberg; Kathryn M Magruder; Christopher W Forsberg; Matthew J Friedman; Brett T Litz; Patrick J Heagerty; Grant D Huang; Theresa C Gleason; Nicholas L Smith Journal: J Psychiatr Res Date: 2014-06-09 Impact factor: 4.791
Authors: Iffat Rahman; Keith Humphreys; Anna Michaela Bennet; Erik Ingelsson; Nancy Lee Pedersen; Patrik Karl Erik Magnusson Journal: Eur J Epidemiol Date: 2013-07-09 Impact factor: 8.082
Authors: Christoph U Correll; Marco Solmi; Nicola Veronese; Beatrice Bortolato; Stella Rosson; Paolo Santonastaso; Nita Thapa-Chhetri; Michele Fornaro; Davide Gallicchio; Enrico Collantoni; Giorgio Pigato; Angela Favaro; Francesco Monaco; Cristiano Kohler; Davy Vancampfort; Philip B Ward; Fiona Gaughran; André F Carvalho; Brendon Stubbs Journal: World Psychiatry Date: 2017-06 Impact factor: 49.548
Authors: Briana Mezuk; Victor Heh; Elizabeth Prom-Wormley; Kenneth S Kendler; Nancy L Pedersen Journal: Psychosom Med Date: 2015-06 Impact factor: 4.312